STAT Plus: Biotech in the time of coronavirus: The return of mergers, acquisitions, and deals
Seeing the Easter Bunny wear a mask was weird. Greetings and welcome to another semi-regular column on the Covid-19 pandemic. In this edition: When will biotech M&A return? Did Sage Therapeutics CEO take a pay cut? Biotech in an America First world; and more chatter about #JPM21.
What will it take for mergers and acquisitions to return to biotech?
